Ignet

Gene Information

Gene symbol: HAVCR1

Gene name: hepatitis A virus cellular receptor 1

HGNC ID: 17866

Synonyms: HAVCR-1, TIM-1, TIM1, HAVCR, TIMD1

Related Genes

#	Gene Symbol	Number of hits
1	CD4	1 hits
2	IFNG	1 hits
3	IL10	1 hits
4	TLR9	1 hits

Related Sentences

#	PMID	Sentence
1	28736945	Tim-1⁺ B cells suppress T cell interferon-gamma production and promote Foxp3 expression, but have impaired regulatory function in coronary artery disease.
2	28736945	Tim-1⁺ B cells suppress T cell interferon-gamma production and promote Foxp3 expression, but have impaired regulatory function in coronary artery disease.
3	28736945	Tim-1⁺ B cells suppress T cell interferon-gamma production and promote Foxp3 expression, but have impaired regulatory function in coronary artery disease.
4	28736945	Tim-1⁺ B cells suppress T cell interferon-gamma production and promote Foxp3 expression, but have impaired regulatory function in coronary artery disease.
5	28736945	Tim-1⁺ B cells suppress T cell interferon-gamma production and promote Foxp3 expression, but have impaired regulatory function in coronary artery disease.
6	28736945	Tim-1⁺ B cells suppress T cell interferon-gamma production and promote Foxp3 expression, but have impaired regulatory function in coronary artery disease.
7	28736945	In healthy individuals, IL-10-producing B cells were predominantly found in the Tim-1⁺ B cells.
8	28736945	In healthy individuals, IL-10-producing B cells were predominantly found in the Tim-1⁺ B cells.
9	28736945	In healthy individuals, IL-10-producing B cells were predominantly found in the Tim-1⁺ B cells.
10	28736945	In healthy individuals, IL-10-producing B cells were predominantly found in the Tim-1⁺ B cells.
11	28736945	In healthy individuals, IL-10-producing B cells were predominantly found in the Tim-1⁺ B cells.
12	28736945	In healthy individuals, IL-10-producing B cells were predominantly found in the Tim-1⁺ B cells.
13	28736945	Upon stimulation of the B cell receptor (BCR) and Toll-like receptor 9 (TLR-9) by anti-BCR antibodies and CpG, respectively, the Tim-1⁺ B cells could further upregulate IL-10 expression.
14	28736945	Upon stimulation of the B cell receptor (BCR) and Toll-like receptor 9 (TLR-9) by anti-BCR antibodies and CpG, respectively, the Tim-1⁺ B cells could further upregulate IL-10 expression.
15	28736945	Upon stimulation of the B cell receptor (BCR) and Toll-like receptor 9 (TLR-9) by anti-BCR antibodies and CpG, respectively, the Tim-1⁺ B cells could further upregulate IL-10 expression.
16	28736945	Upon stimulation of the B cell receptor (BCR) and Toll-like receptor 9 (TLR-9) by anti-BCR antibodies and CpG, respectively, the Tim-1⁺ B cells could further upregulate IL-10 expression.
17	28736945	Upon stimulation of the B cell receptor (BCR) and Toll-like receptor 9 (TLR-9) by anti-BCR antibodies and CpG, respectively, the Tim-1⁺ B cells could further upregulate IL-10 expression.
18	28736945	Upon stimulation of the B cell receptor (BCR) and Toll-like receptor 9 (TLR-9) by anti-BCR antibodies and CpG, respectively, the Tim-1⁺ B cells could further upregulate IL-10 expression.
19	28736945	In contrast, the Tim-1⁺ B cells were present at normal frequency in CAD patients, but showed impaired capacity to upregulate IL-10 with or without BCR + CpG stimulation.
20	28736945	In contrast, the Tim-1⁺ B cells were present at normal frequency in CAD patients, but showed impaired capacity to upregulate IL-10 with or without BCR + CpG stimulation.
21	28736945	In contrast, the Tim-1⁺ B cells were present at normal frequency in CAD patients, but showed impaired capacity to upregulate IL-10 with or without BCR + CpG stimulation.
22	28736945	In contrast, the Tim-1⁺ B cells were present at normal frequency in CAD patients, but showed impaired capacity to upregulate IL-10 with or without BCR + CpG stimulation.
23	28736945	In contrast, the Tim-1⁺ B cells were present at normal frequency in CAD patients, but showed impaired capacity to upregulate IL-10 with or without BCR + CpG stimulation.
24	28736945	In contrast, the Tim-1⁺ B cells were present at normal frequency in CAD patients, but showed impaired capacity to upregulate IL-10 with or without BCR + CpG stimulation.
25	28736945	The stimulated Tim-1⁺ B cells from healthy individuals also suppressed expression of interferon gamma (IFN-γ), an atherogenic cytokine in T cells, in an IL-10-dependent fashion, and strongly promoted the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
26	28736945	The stimulated Tim-1⁺ B cells from healthy individuals also suppressed expression of interferon gamma (IFN-γ), an atherogenic cytokine in T cells, in an IL-10-dependent fashion, and strongly promoted the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
27	28736945	The stimulated Tim-1⁺ B cells from healthy individuals also suppressed expression of interferon gamma (IFN-γ), an atherogenic cytokine in T cells, in an IL-10-dependent fashion, and strongly promoted the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
28	28736945	The stimulated Tim-1⁺ B cells from healthy individuals also suppressed expression of interferon gamma (IFN-γ), an atherogenic cytokine in T cells, in an IL-10-dependent fashion, and strongly promoted the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
29	28736945	The stimulated Tim-1⁺ B cells from healthy individuals also suppressed expression of interferon gamma (IFN-γ), an atherogenic cytokine in T cells, in an IL-10-dependent fashion, and strongly promoted the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
30	28736945	The stimulated Tim-1⁺ B cells from healthy individuals also suppressed expression of interferon gamma (IFN-γ), an atherogenic cytokine in T cells, in an IL-10-dependent fashion, and strongly promoted the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
31	28736945	In contrast, the Tim-1⁺ B cells from CAD patients were unable to suppress IFN-γ secretion, and only minimally increased the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
32	28736945	In contrast, the Tim-1⁺ B cells from CAD patients were unable to suppress IFN-γ secretion, and only minimally increased the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
33	28736945	In contrast, the Tim-1⁺ B cells from CAD patients were unable to suppress IFN-γ secretion, and only minimally increased the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
34	28736945	In contrast, the Tim-1⁺ B cells from CAD patients were unable to suppress IFN-γ secretion, and only minimally increased the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
35	28736945	In contrast, the Tim-1⁺ B cells from CAD patients were unable to suppress IFN-γ secretion, and only minimally increased the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.
36	28736945	In contrast, the Tim-1⁺ B cells from CAD patients were unable to suppress IFN-γ secretion, and only minimally increased the expression of Foxp3 in naive CD4⁺ CD45RO^- T cells.